Donna R. H. Cryer
41 works · 8,613 citations · h-index 11
Top works
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- Advancing the global public health agenda for NAFLD: a consensus statement
- Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
- Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
- Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis
- Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
- Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
- Nonalcoholic fatty liver disease from a primary care perspective
- Development of a New Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis: Nash-Check
- Identifying Credible Sources of Health Information in Social Media: Phase 2—Considerations for Non-Accredited Nonprofit Organizations, For-Profit Entities, and Individual Sources
- Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey
- Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
- Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey
- The importance of patient engagement in the multimodal treatment of MASLD
- Measuring what matters to patients: the development of the NASH-CHECK, a new patient-reported outcome instrument for nonalcoholic steatohepatitis
- Exploring the patient perceived impact of non-alcoholic steatohepatitis
- NASH and liver cancer: the new cancer headline.
- Understanding the patient-perceived impact of nonalcoholic steatohepatitis: Raising the volume on a silent disease